China Healthcare:Data Update,Introducing interim estimates
类型:行业研究 机构:高盛高华证券有限责任公司 研究员:高盛高华证券研究所 日期:2016-11-10
http://www.zdcj.net 点击收藏此报告
We have introduced 1H17 and 2H17 estimates for 3SBio, CMS, Weigao,and Sinopharm. Further, we have introduced quarterly estimates forNHWA Pharma. We do not view these changes as material, and there is nochange to our investment theses, ratings or price targets (summarized inExhibit 1).
相关报告:
热点推荐: